Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05132881 · ClinicalTrials.gov registry record · NA

Effect of (TaVNS) on Anxiety and Brain Function in Distressed Health Care Workers

A NA study of Healthy and Anxiety, sponsored by Thomas Jefferson University.

Active
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT05132881 is a NA study of Healthy and Anxiety that is active but no longer recruiting, run by Thomas Jefferson University. The registered enrollment target is 90 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05132881, a NA study of Healthy and Anxiety, is active but no longer recruiting, sponsored by Thomas Jefferson University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to measure alterations in anxiety and brain activity associated with the use of an approved health device called Transauricular Vagal Nerve Stimulation (TaVNS) in distressed persons who work in a health care and distressed healthcare workers in the the Philadelphia, PA region. The Investigators will be using functional magnetic resonance imaging (or fMRI) to measure changes in each subject's brain function during the use of VNS. This study is designed to allow researchers to understand the changes in cerebral (brain) activity that occur when a subject uses VNS. Thus, the primary goal of the proposed study is to evaluate the ability of the TaVNS system to reduce distress and change neurophysiology among health care providers. The Investigators, hypothesize that using the TaVNS device will help reduce distress in individuals. In order to understand the mechanisms of change that occur while using the VNS study, the Investigators have added a substudy of participants who do not experience high levels of distress to evaluate the effects of the functional changes that may occur in the brain while using the TaVNS device. In addition to the primary aims of the overalll study to assess distress in workers while enrolled in a TaVNS program, a subgroup of 50 subjects will undergo functional magnetic resonance imaging (fMRI) while using the VNS device to assess the changes in the brain including neurophysiological effects of TaVNS. The goal of this substudy is to observe the changes in the brain while using the TaVNS earbuds in the MRI to increase our understanding of the mechanisms and processing involved while using TaVNS. In this substudy, which is amendment version 3.0, the investigators have increased the number of persons to include 50 subjects who will use the device in the MRI to evaluate the neural processes and cerebral blood flow while using TaVNS.

Interventions

  • OTHER Waitlist Control
  • OTHER Neuvana 2.0 Transcutaneous Auricular Vagal Nerve Stimulation (TaVNS)
  • OTHER Healthy Controls: Substudy Group III
  • OTHER Distressed Workers: Subgroup II

Study Locations (1)

Pennsylvania

  • Thomas Jefferson University, Marcus Institute of Integrative Health Centers - Philadelphia

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2021-04-01
Est. Completion 2025-11-20
Phase NA

Sponsor

Thomas Jefferson University

292 total trials

What the Registry Record Tells You About NCT05132881

The ClinicalTrials.gov registry entry for NCT05132881 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (86% lower). The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Healthy appearing as the primary indexed condition, and to 4 interventions - of which Waitlist Control is the first listed.

NCT05132881 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05132881 about?

NCT05132881 is a clinical study titled "Effect of (TaVNS) on Anxiety and Brain Function in Distressed Health Care Workers". The purpose of this research is to measure alterations in anxiety and brain activity associated with the use of an approved health device called Transauricular Vagal Nerve Stimulation (TaVNS) in distressed persons who work in a health care and distressed healthcare workers in the the Philadelphia, P...

What is the current status of trial NCT05132881?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2021-04-01. Estimated completion is 2025-11-20.

What conditions does trial NCT05132881 study?

This clinical trial studies the following conditions: Healthy, Anxiety, Distress, Emotional, Effects of Vibration.

What interventions are being tested in trial NCT05132881?

The interventions under investigation include: Waitlist Control (OTHER), Neuvana 2.0 Transcutaneous Auricular Vagal Nerve Stimulation (TaVNS) (OTHER), Healthy Controls: Substudy Group III (OTHER), Distressed Workers: Subgroup II (OTHER).

Who is sponsoring clinical trial NCT05132881?

This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05132881 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.